Credits: Canva
By the time the world was welcoming 2025, US was crippling with many diseases, some seasonal and some from animals. And as 2025 unfolds, US faces an increasing risk of such diseases, and the reason is also the declining vaccination rates, policy shifts and coming of new pathogens. There are speculations that if Robert F Kennedy Jr is confirmed to head the Department of Health and Human Services (HHS), then it may lead to further decline in vaccination.
Childhood vaccination rates in the U.S. are already declining. Schools have also allowed vaccination exemptions and it is on the rise. As per the Centers for Disease Control and Prevention (CDC), the unvaccinated and undervaccinated populations provide opportunities for outbreaks of diseases like measles. This also saw a significant resurgence in 2024. The CDC also reported over 280 measles cases, the highest in 5 years, seen among unvaccinated individuals. Experts also warn that declining immunization rates may lead to further outbreaks of vaccine-preventable diseases.
While Polio is eradicated in the US, it also remains a concern. Right now, it persists in parts of Pakistan and Afghanistan. The virus also has the possibility to resurface domestically if vaccination rates continue to drop. It can also affect populations that have never experienced the devastating impact of diseases like polio, mumps, and rubella.
Meanwhile, avian influenza remains a serious threat. In 2024, the CDC reported over 60 human cases, including the first serious sickness in the United States. Although human-to-human transmission has not been established, scientists underline the need for surveillance, especially given the gaps in responding to outbreaks in animal communities like dairy farms.
Newly found infections, including as more virulent strains of mpox, are another source of concern. Mpox, a virus similar to smallpox, has largely impacted males who have intercourse with men, but it can be transmitted through personal contact. With the government stockpile no longer providing free vaccines starting in April 2024, monetary constraints may dissuade underprivileged people from obtaining protection.
Experts also closely monitor the idea of "Disease X," which refers to hypothetical, unknown infections capable of producing pandemics. Recent incidents, such as severe malaria previously recognized as Disease X in the Congo, highlight the significance of pandemic preparedness.
Public health experts point towards another pandemic. They are calling it inevitable. The reasons are globalisation, climate change, and decline in vaccine rates. While the specific pathogen and timeline remain uncertain, global health organizations are calling for preparedness, vigilance, and readiness. There are ongoing research, investments and vaccine development, along with public awareness which are increasing to mitigate the risks of the next pandemic.
The lessons can be learnt from 2024 to be prepared in the new year. It also highlights the need for a robust public health system along with evidence-based policies on health, widespread vaccine coverage and also addressing the resurgence of certain infections.
Heart disease remains one of the leading causes of death globally, and while technology has evolved to the point where predicting heart attacks is possible, the medical world still struggles to put this into practice. Experts point to both promise and pitfalls in predictive cardiology, revealing why such life-saving tech is not yet a mainstream reality.
Dr. Vikrant B. Khese, Cardiologist at Jehangir Hospital, Pune, says the idea that we can predict heart attacks before they happen is both “exciting and frustrating, because while the technology exists, its real-world implementation remains limited.”
He explains that artificial intelligence (AI) and machine learning (ML) have incredible potential in this field. These tools can analyse vast datasets, such as blood pressure, lipid profiles, ECGs, imaging, and even genetic markers, to uncover patterns that might be invisible to the human eye. “These tools can detect subtle risk factors that may be missed in routine clinical practice. However, several challenges continue to hold us back,” he says.
One of the biggest concerns is the source of the data feeding these algorithms. “The majority of AI models are trained on Western datasets that do not reflect the unique genetic, environmental, and lifestyle factors of Indian or Asian populations. This creates a mismatch, resulting in lower accuracy and reliability for non-Western patients.”
Dr. Khese adds that cardiovascular disease is deeply multifactorial. It is not just about clinical metrics. “Stress, socioeconomic status, cultural diet patterns, air pollution, and unstructured physical activity all influence risk but are difficult to quantify in a dataset. AI still struggles with these intangible but crucial variables.”
And even when predictive tools are developed, another hurdle lies in the healthcare system’s ability to use them. “Data-driven predictions can only be as good as the data input. In India, inconsistent electronic medical records, underreporting, and fragmented healthcare systems make it harder to gather high-quality longitudinal data, limiting the AI's learning potential.”
Crucially, there is also a behavioural gap. “Even when prediction tools exist, they are not routinely used by clinicians due to scepticism, lack of training, or workflow disruption. Bridging the gap between innovation and implementation is a major hurdle.”
According to Dr. Khese, technology must complement clinical judgement, not replace it. “AI is a powerful tool but not a standalone solution. Until we combine high-quality, representative data with clinical wisdom and system-level integration, the promise of predicting heart attacks before they happen will remain underutilised. The future lies in synergy; technology must empower doctors, not replace them.”
Dr. Vijay D'Silva, Medical Director of White Lotus International Hospital and Clinical Advisor and Mentor of Heartnet India, backs this view and draws attention to major international trials. “Research from the University of Oxford has suggested that a global trial of an AI tool that can predict the 10-year risk of heart attack has shown that in about 45 per cent of patients with chest pain, treatment could be improved,” he shares.
“Early detection of cardiac risk allows timely treatment and monitoring that can help reduce the mortality rate,” he says, explaining that most coronary blockages are asymptomatic. “Some present with chest, arm or jaw pain on exertion (angina pectoris). Few present as a heart attack or sudden death. People seek treatment after a heart attack when the damage is already done.”
According to Dr. D’silva, “With the help of the right tools, it is now possible to predict a heart attack before it occurs.” Among these tools are blood tests, ECGs, and advanced risk calculators such as the AHA PREVENT calculator, ASCVD Risk Calculator Plus, QRISK3, and SCORE2.
He points out how the 2023 AHA PREVENT calculator estimates 10-year cardiovascular risk in individuals aged 30 to 79, and 30-year risk in adults aged 30 to 59. “Early-stage detection of CVD minimises the cost and also reduces the CVD mortality rate,” he says.
This tool divides patients into four risk categories, each with its own treatment strategy:
Despite these advances, Dr D'Silva says, “The gap lies in implementation. Most people still wait for the symptoms to appear before seeing a doctor. Heart attacks, unfortunately, strike without any warning, especially in women and younger patients, where symptoms can be atypical.”
He stresses that predictive cardiology is not yet standard in clinical practice. “People who are at risk seek care when symptoms arise. But in cardiology, symptoms often come too late. Up to 50 per cent of heart attack victims had no prior warning signs.”
Dr. D'silva concludes, “The ability to predict heart attacks is advancing continuously, but we need public awareness and equitable access to make predictive cardiology more standard.”
In short, we can predict heart att but until we normalise risk screening, improve data systems, and bridge the clinical gap, too many heart attacks will continue to catch people and systems off guard.
When strands clog your shower drain or your brush looks full every time you run it through your hair, panic is a natural response. Hair loss, or alopecia, is not just a cosmetic concern; it often hints at something deeper. And yet, thanks to internet half-truths and old wives’ tales, myths about alopecia spread faster than a viral meme. On World Alopecia Day, we turn to experts to separate fact from fiction while spotlighting the hidden medical conditions that might be behind the hair fall.
The good news? “Early diagnosis and treatment of these conditions can help restore hair growth and prevent permanent damage,” he assures.
Myth 1: “Only men experience alopecia.”
“While male pattern baldness is more commonly discussed, women are equally susceptible to alopecia due to hormonal imbalances, thyroid issues, and nutritional deficiencies,” says Dr Gangurde. Yes, ladies lose hair too and not just from brushing too hard.
Myth 2: “Stress alone is responsible for hair loss.”
While stress is definitely not good for your scalp’s health, it is not the lone cause. “Alopecia usually has multiple triggers, including genetics, autoimmune conditions, and underlying medical issues,” explains Dr Gangurde. Translation: stressing about stress causing hair fall might make things worse.
Myth 3: “Alopecia is always permanent and untreatable.”
This one might be the most damaging myth of all. “Many forms of hair loss, especially those caused by hormonal or nutritional factors, are reversible with timely medical intervention,” says Dr Gangurde. PRP therapy, medications, and lifestyle changes can all turn things around if you act early enough.
Do Not Just Shed Tears, Seek Help
If your hair has been thinning or falling out in clumps, resist the urge to DIY it with oils, serums, or social media hacks. “If you experience sudden or persistent hair loss, consult a dermatologist or trichologist promptly,” advises Dr Gangurde. “Early intervention can address the root cause, prevent progression, and in many cases, restore healthy hair growth.” Remember that alopecia is not just a surface-level issue. And with the right diagnosis, it is often more fixable than you think.
Credits: Canva
The 2025 flu season has turned out to be unlike any other in recent memory. This year, the flu season is marked by record-setting infections, multiple viral peaks, vaccine mismatches, and an overstretched healthcare system.
According to the Centers for Disease Control and Prevention (CDC), this year’s influenza activity is the most intense since the 2009 swine flu pandemic, with over 80 million estimated illnesses and rising. What’s driving this intensity, and what should the public know about prevention and symptom management?
Let’s break down what makes this flu season so severe and what it means for your health.
In most years, flu activity in the U.S. typically follows a predictable pattern, starting in October, peaking between December and February, and fading by April. But the 2024–2025 season has defied that rhythm.
Cases surged past the national baseline in December and then, unexpectedly, peaked again in February, a second wave that blindsided doctors and public health experts.
As of March 2025, the CDC had reported an estimated 37 million influenza infections, 480,000 hospitalizations, and 21,000 deaths. Hospitalizations, in fact, reached their highest levels in 15 years.
One key driver? A mismatch between circulating flu strains and this year’s vaccine. The dominant strains: H1N1 and H3N2, accounted for more than 99% of cases.
H3N2, in particular, is known for mutating quickly and evading immune responses, and only about half of circulating H3N2 samples matched well with vaccine antibodies, according to CDC surveillance data.
Another reason this year’s flu is hitting so hard: our immune systems are still catching up.
During the height of the COVID-19 pandemic, widespread masking, social distancing, and school closures suppressed not just SARS-CoV-2 but also seasonal flu and other common respiratory viruses. While that helped in the short term, it reduced community-level immunity over time, especially among children, who typically build natural resistance through repeated exposures.
“Young children who were toddlers or preschoolers during the pandemic missed early exposures to flu viruses,” explained experts at the nonprofit group Families Fighting Flu. “Now they’re in school, more socially active, and more vulnerable.”
The CDC reported a troubling spike in pediatric flu deaths this season with 216 fatalities, making it the deadliest flu season for children outside of a pandemic year. Neurological complications such as seizures and hallucinations also rose among young patients.
Another unusual trend: COVID-19 has taken a back seat this winter
Unlike previous years when COVID-19 variants dominated respiratory illness charts, flu has surged ahead as the top driver of doctor visits and hospitalizations. This could be due to a shift in viral dominance, changing weather patterns, or differences in immunity buildup. According to the CDC, nearly 8% of all outpatient visits are currently for flu-like symptoms, much higher than what’s typical for this time of year.
Vaccine Fatigue and Gaps in Coverage
Vaccination remains the strongest tool we have to fight influenza, but uptake has been stagnant, or worse, declining, in key groups.
As of April 2025:
Barriers like vaccine hesitancy, misinformation, racial and ethnic disparities in healthcare access, and fewer flu shot clinics in rural areas continue to widen the gap.
The 2025 flu has shown typical but often more intense symptoms than in previous years. Here’s what to look out for:
These symptoms may overlap with COVID-19 or RSV, but tend to come on faster and hit harder in flu cases this season.
For most healthy people, flu symptoms begin 1 to 4 days after exposure and typically last about 5 to 7 days. However, fatigue and cough may linger for up to two weeks.
You’re considered most contagious in the first 3 to 4 days after symptoms start but can continue to spread the virus up to a week later. The CDC recommends staying home until you’ve been fever-free for at least 24 hours without medication.
Vaccinated individuals may experience milder or shorter symptoms, but those with underlying conditions, young children, and older adults may have longer recoveries and higher risk of complications.
Yes, especially in people with weakened immune systems, chronic illnesses, or no prior flu immunity.
Possible complications include:
This is why experts stress that prevention remains the best medicine.
Here’s how to lower your risk during the remainder of the 2025 season:
© 2024 Bennett, Coleman & Company Limited